Nasdaq-listed Windtree Therapeutics unveils new funding plans to generate $520 million. Most of the funds will be used to accelerate the firm’s BNB treasury strategy. According to a recent press release, the Nasdaq-listed biotechnology company announced that it has signed…
Related Posts
New crypto tokens are failing in 2025: 85% below TGE prices
New crypto token launches have faced major price declines in 2025, with 84.7% trading below their Token Generation…
This rival memecoin could climb 11,044% by the time SHIB reaches $0.00015
Pepeto’s presale hits $5.98m as token demand surges, with each sale stage closing faster ahead of official launch.…
Ethereum Successfully Transitions to Proof-of-Stake Consensus
The Ethereum blockchain completed its long-awaited Merge update early Thursday morning on September 15, 2022.